HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection.

Abstract
Thai patients enrolled in STACCATO with HIV/hepatitis B virus (HBV) co-infection and tenofovir/emtricitabine-based antiretroviral therapy (ART) were randomly assigned to continuous treatment or CD4 cell count-guided interruptions. HBV replication was suppressed below detection in 15/16 patients. Structured treatment interruption increased transaminases and HBV viraemia in five of six patients; one flare was severe. Conversion to anti-hepatitis Be occurred with continuous treatment only. Tenofovir/emtricitabine-containing ART is highly effective in controlling chronic HIV/HBV co-infection but treatment should not be interrupted.
AuthorsReto Nüesch, Jintanat Ananworanich, Preeyaporn Srasuebkul, Ploenchan Chetchotisakd, Wisit Prasithsirikul, Wirat Klinbuayam, Apicha Mahanontharit, Thidarat Jupimai, Kiat Ruxrungtham, Bernard Hirschel
JournalAIDS (London, England) (AIDS) Vol. 22 Issue 1 Pg. 152-4 (Jan 02 2008) ISSN: 1473-5571 [Electronic] England
PMID18090405 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Retroviral Agents
  • Antiviral Agents
  • Hepatitis B e Antigens
  • Organophosphonates
  • Deoxycytidine
  • Tenofovir
  • Transaminases
  • Emtricitabine
  • Adenine
Topics
  • Adenine (administration & dosage, analogs & derivatives)
  • Anti-Retroviral Agents (administration & dosage)
  • Antiretroviral Therapy, Highly Active
  • Antiviral Agents (administration & dosage)
  • Deoxycytidine (administration & dosage, analogs & derivatives)
  • Drug Administration Schedule
  • Emtricitabine
  • Female
  • HIV
  • HIV Infections (complications, drug therapy)
  • Hepatitis B e Antigens (blood)
  • Hepatitis B virus (immunology, isolation & purification)
  • Hepatitis B, Chronic (blood, complications, drug therapy, virology)
  • Humans
  • Male
  • Organophosphonates (administration & dosage)
  • Tenofovir
  • Thailand
  • Transaminases (blood)
  • Treatment Outcome
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: